Efficacy and safety of bivalirudin bridging enoxaparin versus fondaparinux in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: evidence from a single-center study

CONCLUSIONS: The anticoagulation strategy of bivalirudin bridging fondaparinux seems to be superior to that of bivalirudin bridging enoxaparin in patients with AMI undergoing PPCI.PMID:36817677 | PMC:PMC9897106 | DOI:10.5114/aoms/157287

Source: Archives of Medical Science - February 23, 2023 Category: General Medicine Authors: Yanqing Guo Jingping Wang Zhixin Wang Li Li Jian An Source Type: research